Edesa Biotech, Inc. (EDSA)

Edesa Biotech Statistics

Total Valuation

Edesa Biotech has a market cap or net worth of $115.96 million. The enterprise value is $105.95 million.

Market Cap	115.96M
Enterprise Value	105.95M

Important Dates

The last earnings date was Thursday, May 14, 2026, after market close.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Edesa Biotech has 8.89 million shares outstanding. The number of shares has increased by 102.57% in one year.

Current Share Class	8.89M
Shares Outstanding	8.89M
Shares Change (YoY)	+102.57%
Shares Change (QoQ)	+7.98%
Owned by Insiders (%)	7.96%
Owned by Institutions (%)	5.40%
Float	5.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	63.64
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.76

Current Ratio	4.76
Quick Ratio	4.67
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -81.16% and return on invested capital (ROIC) is -53.49%.

Return on Equity (ROE)	-81.16%
Return on Assets (ROA)	-47.73%
Return on Invested Capital (ROIC)	-53.49%
Return on Capital Employed (ROCE)	-108.00%
Weighted Average Cost of Capital (WACC)	11.28%
Revenue Per Employee	n/a
Profits Per Employee	-$614,343
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Edesa Biotech has paid $800 in taxes.

Income Tax	800
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +542.86% in the last 52 weeks. The beta is 1.28, so Edesa Biotech's price volatility has been higher than the market average.

Beta (5Y)	1.28
52-Week Price Change	+542.86%
50-Day Moving Average	9.01
200-Day Moving Average	3.71
Relative Strength Index (RSI)	52.95
Average Volume (20 Days)	1,077,058

Short Selling Information

The latest short interest is 513,538, so 5.78% of the outstanding shares have been sold short.

Short Interest	513,538
Short Previous Month	267,664
Short % of Shares Out	5.78%
Short % of Float	9.48%
Short Ratio (days to cover)	0.56

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-11.01M
Pretax Income	-10.44M
Net Income	-10.44M
EBITDA	-10.91M
EBIT	-11.01M
Earnings Per Share (EPS)	-$1.37

Balance Sheet

The company has $10.00 million in cash and n/a in debt, with a net cash position of $10.00 million or $1.13 per share.

Cash & Cash Equivalents	10.00M
Total Debt	n/a
Net Cash	10.00M
Net Cash Per Share	$1.13
Equity (Book Value)	10.20M
Book Value Per Share	0.21
Working Capital	8.23M

Cash Flow

Operating Cash Flow	-7.53M
Capital Expenditures	n/a
Depreciation & Amortization	102,987
Net Borrowing	n/a
Free Cash Flow	-7.53M
FCF Per Share	-$0.85

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Edesa Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-102.57%
Shareholder Yield	-102.57%
Earnings Yield	-9.01%
FCF Yield	-6.49%

Analyst Forecast

The average price target for Edesa Biotech is $5.00, which is -61.69% lower than the current price. The consensus rating is "Strong Buy".

Price Target	$5.00
Price Target Difference	-61.69%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 11, 2023. It was a reverse split with a ratio of 1:7.

Last Split Date	Oct 11, 2023
Split Type	Reverse
Split Ratio	1:7

Scores

Altman Z-Score	n/a
Piotroski F-Score	1